Cite
Wang Y, Kuang X, Yin Y, et al. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction. Biomed Pharmacother. 2021;145:112367doi: 10.1016/j.biopha.2021.112367.
Wang, Y., Kuang, X., Yin, Y., Han, N., Chang, L., Wang, H., Hou, Y., Li, H., Li, Z., Liu, Y., Hao, Y., Wei, Y., Wang, X., & Jia, Z. (2022). Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 145112367. https://doi.org/10.1016/j.biopha.2021.112367
Wang, Yafen, et al. "Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 145 (2022): 112367. doi: https://doi.org/10.1016/j.biopha.2021.112367
Wang Y, Kuang X, Yin Y, Han N, Chang L, Wang H, Hou Y, Li H, Li Z, Liu Y, Hao Y, Wei Y, Wang X, Jia Z. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction. Biomed Pharmacother. 2022 Jan;145:112367. doi: 10.1016/j.biopha.2021.112367. Epub 2021 Nov 02. PMID: 34740097.
Copy
Download .nbib